Virbac SA

Informe acción ENXTPA:VIRP

Capitalización de mercado: €2.8b

Virbac Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Virbac de 10.8% y 5.9% por año respectivamente. Se prevé que el BPA crezca en un 10.6% al año. Se espera que la rentabilidad financiera sea de 13.9% en 3 años.

Información clave

10.8%

Tasa de crecimiento de los beneficios

10.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals17.1%
Tasa de crecimiento de los ingresos5.9%
Rentabilidad financiera futura13.9%
Cobertura de analistas

Good

Última actualización22 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Virbac SA Just Beat Revenue Estimates By 6.0%

Sep 18
Virbac SA Just Beat Revenue Estimates By 6.0%

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Mar 22
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Recent updates

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 47% Undervalued

Oct 06
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 47% Undervalued

Virbac SA Just Beat Revenue Estimates By 6.0%

Sep 18
Virbac SA Just Beat Revenue Estimates By 6.0%

Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares

Aug 31
Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Jun 15
Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Jun 10
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected

May 21
Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Mar 22
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Jan 18
Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Dec 27
Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Oct 19
Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Sep 26
Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Sep 05
Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Jun 20
A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

May 31
Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

Is Virbac (EPA:VIRP) Using Too Much Debt?

Apr 09
Is Virbac (EPA:VIRP) Using Too Much Debt?

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Feb 28
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 25
Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Oct 14
Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

Aug 07
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Jun 26
These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

May 01
Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Mar 26
We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Jan 26
Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Dec 28
Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Oct 27
A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Is Virbac (EPA:VIRP) Using Too Much Debt?

Oct 12
Is Virbac (EPA:VIRP) Using Too Much Debt?

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Sep 26
Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Jul 15
Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Jun 27
Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Is Virbac (EPA:VIRP) A Risky Investment?

May 27
Is Virbac (EPA:VIRP) A Risky Investment?

Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Mar 24
Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Mar 12
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Feb 22
Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Feb 03
Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 05
Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Dec 18
Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Previsiones de crecimiento de beneficios e ingresos

ENXTPA:VIRP - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20261,5661851272297
12/31/20251,4831661072018
12/31/20241,401150791729
6/30/20241,33914174139N/A
3/31/20241,29313166129N/A
12/31/20231,24712159119N/A
9/30/20231,22912069124N/A
6/30/20231,21011978129N/A
3/31/20231,21312162114N/A
12/31/20221,2161224599N/A
9/30/20221,1841203891N/A
6/30/20221,1511193184N/A
3/31/20221,10711657107N/A
12/31/20211,06411383130N/A
9/30/20211,02513780122N/A
6/30/202198516177113N/A
3/31/202196014883116N/A
12/31/202093413690119N/A
9/30/2020944104106133N/A
6/30/202095372123146N/A
3/31/202094662116139N/A
12/31/201993852109132N/A
9/30/20199214392119N/A
6/30/20199033476106N/A
3/31/2019886276395N/A
12/31/2018869205084N/A
9/30/201886285893N/A
6/30/2018854-466103N/A
3/31/2018858-3N/A105N/A
12/31/2017862-3N/A108N/A
9/30/201787116N/A112N/A
6/30/201787935N/A117N/A
3/31/201787635N/A130N/A
12/31/201687235N/A142N/A
9/30/201686130N/A119N/A
6/30/201685026N/A95N/A
3/31/201685118N/A71N/A
12/31/20158539N/A46N/A
9/30/201584621N/A59N/A
6/30/201583932N/A72N/A
3/31/201580648N/A74N/A
12/31/201477364N/A76N/A
9/30/201475260N/A77N/A
6/30/201473056N/A78N/A
3/31/201473358N/A76N/A
12/31/201373661N/A74N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (10.8% al año) de VIRP es superior a la tasa de ahorro (1.4%).

Beneficios vs. Mercado: Se prevé que los beneficios (10.8% al año) de VIRP crezcan menos que el mercado French (12.5% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de VIRP crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (5.9% al año) de VIRP crezcan más rápidamente que los del mercado French (5.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 5.9% al año) de VIRP crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de VIRP sea baja dentro de 3 años (13.9%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y